Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
3.060
+0.210 (7.37%)
Jan 22, 2026, 1:05 PM EST - Market open
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $32.63 million as of January 22, 2026. Its market cap has decreased by -31.87% in one year.
Market Cap
32.63M
Enterprise Value
25.16M
1-Year Change
-31.87%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $32.63M, a decrease of -73.92%. That is a compound annual growth rate of -52.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 30.39M | 48.98% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |